Following the linear regression analysis of HAR1A, HAR1B, and REST, we determined whether aberrant expression of these lncRNAs and REST impacted glioma patient prognosis, using a Kaplan Meier analysis (Fig 2). This evidence concerns the gene HAR1A and central nervous system cancer.